Cambridge Investment Research Advisors’s Natera NTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$722K Sell
2,659
-60
-2% -$12.8K ﹤0.01% 2616
2026
Q1
$544K Buy
2,719
+450
+20% +$96.8K ﹤0.01% 2721
2025
Q4
$520K Sell
2,269
-13
-0.6% -$2.71K ﹤0.01% 2685
2025
Q3
$367K Sell
2,282
-1,628
-42% -$258K ﹤0.01% 2949
2025
Q2
$661K Buy
3,910
+2,219
+131% +$346K ﹤0.01% 2286
2025
Q1
$239K Buy
1,691
+12
+0.7% +$1.93K ﹤0.01% 3070
2024
Q4
$266K Buy
+1,679
New +$245K ﹤0.01% 2933

Other funds holding NTRA

Cambridge Investment Research Advisors's NTRA Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Natera (NTRA) stake by 2.2% in Q2 2026, selling an estimated $12.8K and leaving 2,659 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #2616.

Cambridge Investment Research Advisors first reported a position in NTRA in Q4 2024 and has held it in 7 quarters since. 845 funds tracked by Wall St. Rank hold NTRA as of Q2 2026.

  • Cambridge Investment Research Advisors held 2,659 shares of Natera worth $722K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 60 Natera shares in Q2 2026, an estimated $12.8K.
  • Natera made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2616 holding.
  • Cambridge Investment Research Advisors first reported a position in Natera in Q4 2024 and has held it in 7 quarters since.
  • 845 funds tracked by Wall St. Rank held Natera as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.